Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for CBGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
August 31, 2025 0.0116M
May 31, 2025 0.0116M
February 28, 2025 0.0116M
November 30, 2024 0.0116M
August 31, 2024 0.0116M
May 31, 2024 0.0116M
February 29, 2024 0.0116M
November 30, 2023 0.0116M
August 31, 2023 0.0116M
May 31, 2023 0.0116M
February 28, 2023 0.0123M
November 30, 2022 0.0341M
August 31, 2022 0.0855M
May 31, 2022 0.2534M
February 28, 2022 0.604M
November 30, 2021 0.0889M
August 31, 2021 0.0308M
May 31, 2021 0.268M
February 28, 2021 0.1342M
November 30, 2020 0.0599M
August 31, 2020
May 31, 2020 0.0849M
February 29, 2020 0.157M
November 30, 2019 0.0647M
August 31, 2019 0.1521M
Date Value
May 31, 2019 0.00
February 28, 2019 0.0046M
November 30, 2018 0.0047M
August 31, 2018 0.0047M
May 31, 2018 0.0048M
February 28, 2018 0.0047M
November 30, 2017 0.0048M
August 31, 2017 0.0048M
May 31, 2017 0.0049M
February 28, 2017 0.0049M
November 30, 2016 0.005M
August 31, 2016 0.005M
May 31, 2016 0.0052M
February 29, 2016 0.0054M
November 30, 2015 0.0056M
August 31, 2015 0.0058M
May 31, 2015 0.0154M
February 28, 2015 0.0214M
November 30, 2014 0.0435M
August 31, 2014 0.0517M
May 31, 2014 0.0597M
February 28, 2014 0.0705M
November 30, 2013 0.0109M
August 31, 2013 0.0211M
May 31, 2013 0.0274M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Filana Therapeutics, Inc. 82.68M
CorMedix, Inc. 257.35M
Eloxx Pharmaceuticals, Inc. 61.97M
Breakthrough Chemistry, Inc. 1.215M
BioStem Technologies, Inc. 6.962M